Directors' Long Term Incentive Scheme Share Issue

RNS Number : 0854Q

Futura Medical PLC

12 October 2011

 



For Immediate Release

12 October 2011

Futura Medical plc

("Futura" or "the Company")

Directors' Long Term Incentive Scheme Share Issue

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, confirms that, following its announcement of 27 September 2011, the 417,678 new ordinary shares issued in relation to the realisation of units under its Long Term Incentive Scheme are expected to be admitted to trading on AIM on 17 October 2011.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Jessica Fontaine	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

LISZMMMGVZVGMZM